Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SMH vs GSK✓SelectedUSD · GSKSMH vs GSK performance historyLatest closeAs of-5.11%11/16
Stock and ETF performance explorer

SMH vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,002.4%
GSK return
+201.8%
Excess return
+800.6%
Maximum drawdown
-85.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.1%-0.1%-5.0%-5.1%
7D-5.2%-1.3%-3.9%-4.7%
30D-14.4%+2.7%-17.2%-15.7%
3M-21.4%+2.7%-24.1%-23.0%
6M-17.0%+3.3%-20.3%-19.6%
YTD+28.3%+6.5%+21.8%+21.5%
1Y+34.3%+10.7%+23.6%+24.9%
3Y+189.3%+64.4%+125.0%+115.1%
5Y+212.6%+46.7%+165.9%+139.5%
10Y+1,359.3%+109.4%+1,250.0%+819.9%
All+1,002.4%+201.8%+800.6%+414.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling